Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
7 mg/kg after oral treatment
Chemical Name: 6-(4-bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide
Formula: C17H8Cl3N3O2
Bioymifi directly targets DR5
it also has specific neurological effects
RA190 - Ubiquitin Receptor RPN13/ADRM1 Inhibitor. CAS# 1617495-03-0 60256 7 mg/kg after oral treatmentRA190, CAS No. 1617495 03 0, is a novel potent and selective inhibitor of proteasome Ubiquitin receptor RPN13 ADRM1. It covalently binds to the cysteine 88 of ubiquitin receptor RPN13 in the 19S regulatory particle and inhibits proteasome function, triggering rapid accumulation of polyubiquitinated proteins. Multiple myeloma (MM) lines, even those resistant to bortezomib, were sensitive to RA190 via endoplasmic reticulum stress related apoptosis.